IDEXX Laboratories Inc. (IDXX)
IDEXX Laboratories Max Pain By Strike
IDXX trades at $651.27, 6.8% above the near-term max pain of $610 expiring Aug 15, 2025 (-1 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($490-$620), reflecting growing call interest at higher strikes. High dispersion in max pain levels suggests competing forces and potential volatility.
IDEXX Laboratories Max Pain By Expiry
Max pain for IDXX shows an upward trend from 490 to 620, suggesting bullish positioning in longer-dated options. The 23% spread signals divergent expectations across timeframes. Most levels below 651.27 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 610 | -41.27 (-6.34%) |
| Sep 19, 2025 | 620 | -31.27 (-4.80%) |
| Oct 17, 2025 | 600 | -51.27 (-7.87%) |
| Dec 19, 2025 | 490 | -161.27 (-24.76%) |
| Jan 16, 2026 | 560 | -91.27 (-14.01%) |
| Apr 17, 2026 | 510 | -141.27 (-21.69%) |